Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print August 27, 2003, 10.1148/radiol.2291020726
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2291020726v1
229/1/119    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pastor, C. M.
Right arrow Articles by Vallée, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pastor, C. M.
Right arrow Articles by Vallée, J.-P.
(Radiology 2003;229:119-125.)
© RSNA, 2003


Experimental Studies

Kinetics of Gadobenate Dimeglumine in Isolated Perfused Rat Liver: MR Imaging Evaluation1

Catherine M. Pastor, MD, PhD, Corinne Planchamp, PhD, Sibylle Pochon, PhD, Vito Lorusso, PhD, Xavier Montet, MD, Joachim Mayer, PhD, François Terrier, MD and Jean-Paul Vallée, MD, PhD

1 From the Department of Radiology, Hôpital Universitaire de Genève, Rue Micheli-du-Crest 24, Bâtiment C, Room 6-795, 1211 Geneva 14, Switzerland (C.M.P., X.M., F.T., J.P.V.), Pharmacy Section, Université de Lausanne, Switzerland (C.P., J.M.); Bracco Research, Geneva, Switzerland (S.P.); and Bracco Research, Milan, Italy (V.L.). Received June 10, 2002; revision requested August 20; final revision received November 26; accepted January 28, 2003. C.M.P. supported by Fond National Suisse de la Recherche Scientifique grants 3200-063619.00 and 3200-100868. Address correspondence to C.M.P. (e-mail: catherine.pastor@hcuge.ch).

PURPOSE: To compare in the entire liver, the hepatic kinetics of gadobenate dimeglumine (Gd-BOPTA) and gadopentetate dimeglumine (Gd-DTPA) and to evaluate the hepatic transport of Gd-BOPTA.

MATERIALS AND METHODS: The authors studied both contrast agents in isolated perfused rat livers by measuring the magnetic resonance (MR) signal intensity (SI) in 12 rats, as well as the gadolinium concentrations in hepatic tissues in 42 rats. The intrahepatic transport of Gd-BOPTA was investigated with pharmacologic antagonism by using bromosulfophthalein. MR imaging was performed at 1.5 T with a fast gradient-echo T1-weighted MR sequence.

RESULTS: The hepatic kinetics based on the MR SI measured over time showed a rapid steady state during Gd-DTPA perfusion, while the SI continuously increased during the 30-minute Gd-BOPTA perfusion period. The pharmacokinetic modeling indicated that the half-lives of Gd-DTPA entry and exit were identical (mean, 1.3 minutes ± 0.9 [standard error of mean]) and shorter than those observed with Gd-BOPTA (P < .001). The uptake of Gd-BOPTA was faster (mean half-life, 4.8 minutes ± 0.3) than the washout (mean half-life, 17.5 minutes ± 2.8) (P = .001). The combined perfusion of bromosulfophthalein and Gd-BOPTA decreased the SI enhancement in comparison with the perfusion of Gd-BOPTA alone (mean, 0.56 ± 0.03 vs 2.54 ± 0.39, P < .001). The entry and exit kinetic parameters obtained during the perfusion of Gd-BOPTA plus bromosulfophthalein were identical and comparable to those obtained during Gd-DTPA perfusion (P = .95). Acute bile duct ligation did not interfere with the uptake of Gd-BOPTA in hepatocytes, but it slowed down the excretion by approximately 50%. Measurements of gadolinium concentrations in hepatic tissues confirmed these findings.

CONCLUSION: In the liver, the hepatospecific contrast agent Gd-BOPTA enters into hepatocytes likely through the organic anion transporting peptide 1.

© RSNA, 2003

Index terms: Animals • Contrast media, experimental studies • Experimental study • Gadolinium • Liver, MR, 76.121412, 76.121416, 76.12143 • Magnetic resonance (MR), contrast media, 76.12143 • Radiobiology, cell and tissue studies




This article has been cited by other articles:


Home page
RadiologyHome page
H. Barash, E. Gross, I. Matot, Y. Edrei, G. Tsarfaty, G. Spira, I. Vlodavsky, E. Galun, and R. Abramovitch
Functional MR Imaging during Hypercapnia and Hyperoxia: Noninvasive Tool for Monitoring Changes in Liver Perfusion and Hemodynamics in a Rat Model
Radiology, June 1, 2007; 243(3): 727 - 735.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Planchamp, A. Hadengue, B. Stieger, J. Bourquin, A. Vonlaufen, J.-L. Frossard, R. Quadri, C. D. Becker, and C. M. Pastor
Function of Both Sinusoidal and Canalicular Transporters Controls the Concentration of Organic Anions within Hepatocytes
Mol. Pharmacol., April 1, 2007; 71(4): 1089 - 1097.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Libra, C. Fernetti, V. Lorusso, M. Visigalli, P. L. Anelli, F. Staud, C. Tiribelli, and L. Pascolo
Molecular Determinants in the Transport of a Bile Acid-Derived Diagnostic Agent in Tumoral and Nontumoral Cell Lines of Human Liver
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 809 - 817.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
L. Grazioli, G. Morana, M. A. Kirchin, and G. Schneider
Accurate Differentiation of Focal Nodular Hyperplasia from Hepatic Adenoma at Gadobenate Dimeglumine-enhanced MR Imaging: Prospective Study
Radiology, July 1, 2005; 236(1): 166 - 177.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2003 by the Radiological Society of North America.